Category: Covid-19 Vaccine

There are 4 program areas to support the funding goals. Applicants may apply to more than one program area. See RFA for more information and detailed instructions. There are no set award amounts or award maximums; please submit a funding request that is appropriate for your agency needs.

This program will fund projects/activities that use authentic community engagement practices to gather community input on population-specific assets and needs related to health equity and the COVID-19 pandemic.

This program will provide support for community health navigators to do vaccine outreach, patient education, and health system navigation.

This program will fund activities focused on community resilience related to the social determinants of health as they relate to COVID-19's impact on communities.

The goal of this program is to improve vaccine education, outreach, access, and administration in communities.

Link:

COVID-19 Health Equity and Immunization Funding Opportunity RFA #40624 - Colorado COVID-19 Updates

COVID-19 vaccination, incidence, and mortality rates among indigenous populations compared to the general population in Brazil: Describing trends over time  The Lancet

See the rest here:

COVID-19 vaccination, incidence, and mortality rates among indigenous populations compared to the general population in Brazil: Describing trends over...

Booking COVID-19 Vaccination for Children Six Months to Five Years Starts July 21 and 22 | News and Media  Government of Saskatchewan

See the rest here:

Booking COVID-19 Vaccination for Children Six Months to Five Years Starts July 21 and 22 | News and Media - Government of Saskatchewan

The West Virginia Department of Health and Human Resources (DHHR) reports as of July 20, 2022, there are currently 2,957 active COVID-19 cases statewide. There have been nine deaths reported since the last report, with a total of 7,115 deaths attributed to COVID-19.

DHHR has confirmed the deaths of a 67-year old male from Wyoming County, an 86-year old male from Putnam County, a 93-year old male from Boone County, a 67-year old female from Boone County, an 84-year old male from Ohio County, a 93-year old male from Cabell County, a 92-year old male from Berkeley County, an 81-year old female from Marshall County, and a 90-year old female from Mason County.

Many communities within our state have been affected by the loss of loved ones due to COVID-19, said Bill J. Crouch, DHHR Cabinet Secretary. Protect yourself and your community by receiving the COVID-19 vaccine and boosters.

CURRENT ACTIVE CASES PER COUNTY: Barbour (22), Berkeley (154), Boone (46), Braxton (22), Brooke (22), Cabell (169), Calhoun (7), Clay (12), Doddridge (4), Fayette (88), Gilmer (11), Grant (19), Greenbrier (61), Hampshire (40), Hancock (19), Hardy (27), Harrison (133), Jackson (37), Jefferson (81), Kanawha (292), Lewis (30), Lincoln (33), Logan (70), Marion (98), Marshall (46), Mason (42), McDowell (45), Mercer (159), Mineral (34), Mingo (36), Monongalia (143), Monroe (26), Morgan (15), Nicholas (54), Ohio (49), Pendleton (3), Pleasants (14), Pocahontas (12), Preston (28), Putnam (109), Raleigh (178), Randolph (23), Ritchie (12), Roane (30), Summers (16), Taylor (25), Tucker (14), Tyler (11), Upshur (41), Wayne (42), Webster (18), Wetzel (35), Wirt (1), Wood (141), Wyoming (58). To find the cumulative cases per county, please visit coronavirus.wv.gov and look on the Cumulative Summary tab which is sortable by county.

West Virginians ages 6 months and older are recommended to get vaccinated against the virus that causes COVID-19. Those 5 years and older should receive a booster shot when due. Second booster shots for those age 50 and over who are 4 months or greater from their first booster are recommended, as well as for younger individuals over 12 years old with serious and chronic health conditions that lead to being considered moderately to severely immunocompromised.

Visit the WV COVID-19 Vaccination Due Date Calculator, a free, online tool that helps individuals figure out when they may be due for a COVID-19 shot, making it easier to stay up-to-date on COVID-19 vaccination. To learn more about COVID-19 vaccines, or to find a vaccine site near you, visit vaccinate.wv.gov or call 1-833-734-0965.

Follow this link:

COVID-19 Daily Update 7-20-2022 - West Virginia Department of Health and Human Resources

COVID-19 vaccines were more effective during the winter omicron surge, when BA.1 accounted for most cases, than they were this spring, when BA.2/BA.2.12.1 prevailed, according to a CDC study.

The results bolster the case for vaccine-makers to tweak their formulas and issue omicron-targeted doses, which are expected to debut this fall pending FDA and CDC approval.

Before patients received any boosters, vaccine effectiveness was 61 percent between December 2021 and March 2022 when omicron BA.1 accounted for more than 75 percent of cases. Between March and June, when BA.2/BA.2.12.1 was dominant, that same measure fell to 24 percent, according to the study.

To determine efficacy, the researchers evaluated emergency care visits and hospitalization rates among those with Pfizer and Moderna's two-dose vaccines and subsequent booster shots.

Boosters helped bridge the gap but still shrunk in efficacy over time. Among patients with a booster when BA.1 made up the majority of cases, vaccine efficacy was 92 percent. When BA.2.12.1 surpassed BA.1, vaccine efficacy was 69 percent among those with a booster dose.

When fourth booster doses for adults over 50 rolled out in late March, the study found they also improved vaccine efficacy up to 80 percent.

The overall decrease in efficacy isn't too surprising, since the vaccines were more effective during delta's reign before omicron entered the scene, according to the study. But as omicron subvariant BA.5 now sweeps the nation and COVID-19-related hospital admissions rise, eyes are on vaccine manufacturers to reverse this trend.

The rest is here:

COVID-19 vaccine effectiveness waned as omicron mutated, CDC finds - Becker's Hospital Review

The raceto develop a vaccine against covid-19 was a matter of life and death. A recent study found that in 2021,20m lives were saved by the jabs. Researchers at Airfinity, a life-sciences data firm, have used those numbersalong with data on which shots were most widely administered in each countryto estimate which one averted the most deaths.

Airfinity found that more than half of lives saved around the world could be attributed to just two vaccines.

Read more from The Economist

Go here to read the rest:

Which Covid-19 Vaccine Saved the Most Lives in 2021? - gvwire.com

CURRENT ACTIVE CASES PER COUNTY: Barbour (21), Berkeley (147), Boone (51), Braxton (19), Brooke (14), Cabell (173), Calhoun (6), Clay (12), Doddridge (7), Fayette (93), Gilmer (9), Grant (19), Greenbrier (62), Hampshire (42), Hancock (18), Hardy (23), Harrison (128), Jackson (20), Jefferson (64), Kanawha (271), Lewis (29), Lincoln (36), Logan (50), Marion (100), Marshall (47), Mason (47), McDowell (43), Mercer (160), Mineral (32), Mingo (41), Monongalia (152), Monroe (24), Morgan (13), Nicholas (51), Ohio (57), Pendleton (4), Pleasants (17), Pocahontas (17), Preston (21), Putnam (99), Raleigh (189), Randolph (12), Ritchie (15), Roane (38), Summers (9), Taylor (22), Tucker (11), Tyler (14), Upshur (35), Wayne (33), Webster (16), Wetzel (35), Wirt (0), Wood (133), Wyoming (58). To find the cumulative cases per county, please visit coronavirus.wv.gov and look on the Cumulative Summary tab which is sortable by county.

West Virginians ages 6 months and older are recommended to get vaccinated against the virus that causes COVID-19. Those 5 years and older should receive a booster shot when due. Second booster shots for those age 50 and over who are 4 months or greater from their first booster are recommended, as well as for younger individuals over 12 years old with serious and chronic health conditions that lead to being considered moderately to severely immunocompromised.

Visit the WV COVID-19 Vaccination Due Date Calculator, a free, online tool that helps individuals figure out when they may be due for a COVID-19 shot, making it easier to stay up-to-date on COVID-19 vaccination. To learn more about COVID-19 vaccines, or to find a vaccine site near you, visit vaccinate.wv.gov or call 1-833-734-0965.

To locate COVID-19 testing near you, please visit https://dhhr.wv.gov/COVID-19/pages/testing.aspx.

Originally posted here:

COVID-19 Daily Update 7-18-2022 - West Virginia Department of Health and Human Resources

A nurse fills up syringes with the coronavirus disease (COVID-19) vaccines for residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin

Register

July 18 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

Blood thickness linked with death risk in severe COVID-19

Patients hospitalized with COVID-19 whose blood flows less freely than normal are at higher risk of death from complications, a U.S. study showed. The findings indicate that measurement of blood viscosity, or blood thickness, should be a regular part of these patients' medical work-up, the researchers said.

Register

High blood viscosity impairs flow to small vessels and increases the risk of blood clots, the researchers noted in the study published on Monday in the Journal of the American College of Cardiology. Data on 5,621 COVID-19 patients treated at six New York City-area hospitals between February 2020 and November 2021 showed that patients with high viscosity had death rates 38% to 60% higher than those with low blood viscosity. The inflammation associated with COVID-19 likely contributes to high viscosity, which in turn can lead to damage to blood vessel linings and clogging of arteries, according to the researchers.

"This study demonstrates the importance of checking for blood viscosity in COVID-19 patients early in hospital admission, which is easily obtained through routine lab work," Dr. Robert Rosenson of the Mount Sinai Health System said in a statement. His team called for further studies to see whether measures to reduce blood viscosity, such as treatment with blood thinning drugs, would be helpful.

Few excess effects of COVID-19 booster, flu shot together

People who get a flu shot at the same time as a COVID-19 mRNA vaccine booster are only slightly more likely to report side effects than people who get the booster by itself, U.S. researchers found. Earlier studies found that giving flu shots and COVID-19 vaccines at the same time did not make either one less effective and may be more convenient. As reported on Friday in the journal JAMA Network Open, researchers tracked 981,099 American teens and adults who got vaccine boosters with or without flu shots in September or October 2021. In the following week, reports by study participants of a "systemic" reaction such as fatigue, headache or body aches were 8% higher for those who simultaneously received the flu shot and the Pfizer-BioNTech booster and 11% higher for those who got the flu shot and a Moderna booster, compared to the risk in people who received only an mRNA vaccine booster. Based on the results, "clinicians can confidently inform patients that concurrent administration of the COVID-19 booster and seasonal influenza vaccine is both safe and associated with only a slight increase in adverse events compared with the COVID-19 booster alone," a separate team of researchers wrote in an accompanying editorial.

Kids with vaccine allergies safely receive Pfizer shots

The Pfizer mRNA COVID-19 vaccine can be safely given to children even after a suspected allergic reaction to the first dose or a suspected allergy to vaccine ingredients polyethylene glycol (PEG) or polysorbate, according to immunologists. Other allergists previously reported that second doses can be given to adults with suspected reactions to the first dose. Study results involving a small number of children were published on Wednesday in The Journal of Allergy and Clinical Immunology: In Practice. At a specialized vaccine clinic, nine children were evaluated after having an allergic reaction to the first dose of the vaccine, including three who experienced potentially life-threatening anaphylaxis. All nine children - including one who was premedicated - eventually received the second dose "with minimal or no symptoms," the researchers said. Another three children with histories of potential PEG/polysorbate reactions opted to receive the vaccine at the clinic and tolerated both doses without allergic symptoms.

"Any child who experiences potential anaphylaxis following vaccination should absolutely be evaluated," study leader Dr. Joel Brooks of Children's National Hospital in Washington said in a news release. "The benefits and risks must be weighed carefully when it comes to a second dose. However, we have demonstrated that for this study, most of the initial allergic reactions did not meet the criteria of anaphylaxis and our participants were able to tolerate a second dose of the vaccine."

Click for a Reuters Global COVID-19 Tracker and for a Reuters COVID-19 Vaccination Tracker.

Register

Reporting by Nancy Lapid; Editing by Will Dunham

Our Standards: The Thomson Reuters Trust Principles.

Excerpt from:

High blood thickness ups death risk; few problems with flu-COVID shots together - Reuters.com

Vaccines were our way out of this pandemic, and now they will make sure Covid can never haunt us in the same way again.

LONDON (AP) The British government said Friday that everyone 50 or over will be offered a fourth dose of coronavirus vaccine in the fall, lowering the age threshold from the previously announced 65.

The Department of Health said it had accepted advice from the U.K.s independent vaccines adviser about the autumn booster program.

Fourth doses will also be given to health care workers, nursing home staff and residents, and all those aged 5 and up with health conditions that make them more vulnerable to severe illness from Covid-19.

Most of the same groups will also get a free flu shot.

British Prime Minister Boris Johnson said the booster campaign would keep our defenses strong over autumn and winter.

Vaccines were our way out of this pandemic, and now they will make sure Covid can never haunt us in the same way again, he said.

Like many European countries, Britain is experiencing a surge in Covid-19 cases, driven by the ultra-contagious BA.4 and BA.5 subvariants of the omicron strain. The Office for National Statistics estimates that 1 in 19 people in England had the virus in the week ending July 6.

The U.K. has one of Europes highest official death tolls in the pandemic, with almost 178,000 confirmed deaths of people who tested positive.

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

See the original post here:

UK to offer 4th Covid-19 vaccine shot to all 50 and over - Courthouse News Service

The omicron BA.5 sub-variant Is making up most new cases here in New Mexico. This as cases continue to surge across the state. Last November, the first COVID-19 booster shot was approved for the public. Now, eight months later, there's a second booster but it's only available for people over 50 or those who are immunocompromised. So why isn't it available to everyone? Doctors tell KOAT there's a new vaccine just around the corner. One that's created to specifically target omicron variants like BA.5.KOAT medical expert Dr. Barry Ramo said, There are vaccines being developed now that are much more specific for the omicron and the omicron variants. The problem is not going away and the best way to protect yourself has been vaccination.Dr. Meghan Brett from UNMH said, There are vaccines that probably will be available in the very near future that will target multiple strains of COVID-19. Not just the original strain, but also more omicron specific strains that would be added to the COVID vaccines.The Centers for Disease Control and Prevention was asking anyone under 50 with no underlying conditions to hold off on getting the second COVID-19 booster and wait for those new omicron-specific vaccines. Now that nearly 40 states are projected to see increases in hospitalizations the CDC and Food and Drug Administration are considering making that second booster available to all adults.Brett says we should expect to see those new vaccines this coming fall, in order to try and avoid the winter case surge weve seen for the last two years.

The omicron BA.5 sub-variant Is making up most new cases here in New Mexico. This as cases continue to surge across the state.

Last November, the first COVID-19 booster shot was approved for the public. Now, eight months later, there's a second booster but it's only available for people over 50 or those who are immunocompromised.

So why isn't it available to everyone? Doctors tell KOAT there's a new vaccine just around the corner. One that's created to specifically target omicron variants like BA.5.

KOAT medical expert Dr. Barry Ramo said, There are vaccines being developed now that are much more specific for the omicron and the omicron variants. The problem is not going away and the best way to protect yourself has been vaccination.

Dr. Meghan Brett from UNMH said, There are vaccines that probably will be available in the very near future that will target multiple strains of COVID-19. Not just the original strain, but also more omicron specific strains that would be added to the COVID vaccines.

The Centers for Disease Control and Prevention was asking anyone under 50 with no underlying conditions to hold off on getting the second COVID-19 booster and wait for those new omicron-specific vaccines. Now that nearly 40 states are projected to see increases in hospitalizations the CDC and Food and Drug Administration are considering making that second booster available to all adults.

Brett says we should expect to see those new vaccines this coming fall, in order to try and avoid the winter case surge weve seen for the last two years.

Read the original post:

New COVID-19 vaccines that target omicron variants in the works - KOAT New Mexico